Optimapharm Acquires Czech MKS Research

January 11, 2018

Applied Clinical Trials

Following the global trend of consolidating market positions of clinical research organizations (CROs), Optimapharm acquired the Czech CRO company MKS Research. With this acquirement, Optimapharm hopes to strengthen its clientele across the pharmaceutical and biotech industries all while building revenue.

Read the full release here.

Related Content:

News